Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BUDD-CHIARI SYNDROME, SUSCEPTIBILITY TO, SOMATIC
|
1 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.700 | 0 | ||||||||
Splenomegaly
|
19 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.700 | 0 | ||||||||
Behcet Syndrome
|
243 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1 | 2012 | 2012 | ||||||
Blast Phase
|
14 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1 | 2006 | 2006 | ||||||
Hormone refractory prostate cancer
|
29 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1 | 2010 | 2010 | ||||||
Myelodysplastic-Myeloproliferative Diseases
|
1 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1 | 2013 | 2013 | ||||||
Myeloid Leukemia
|
7 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1 | 2010 | 2010 | ||||||
Trigeminal Neuralgia
|
1 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1 | 2018 | 2018 | ||||||
Vascular Hemostatic Disorders
|
1 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.010 | 1 | 2014 | 2014 | ||||||
Acute monocytic leukemia
|
22 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.020 | 0.500 | 2 | 2007 | 2018 | |||||
Lymphoproliferative Disorders
|
14 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.020 | 0.500 | 2 | 2007 | 2009 | |||||
Myelofibrosis due to another disorder
|
6 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.040 | 0.750 | 4 | 2006 | 2010 | |||||
secondary acute myeloid leukemia
|
8 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.050 | 0.800 | 5 | 2007 | 2018 | |||||
Leukocytosis
|
4 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 0.818 | 11 | 2006 | 2017 | |||||
Adult Myelodysplastic Syndrome
|
20 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.060 | 0.833 | 6 | 2006 | 2018 | |||||
Childhood Myelodysplastic Syndrome
|
20 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.060 | 0.833 | 6 | 2006 | 2018 | |||||
Hepatic Vein Thrombosis
|
4 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.070 | 0.857 | 7 | 2006 | 2016 | |||||
Myeloid Leukemia, Chronic
|
115 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 0.889 | 18 | 2008 | 2019 | |||||
Budd-Chiari Syndrome
|
4 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.770 | 0.900 | 10 | 2006 | 2016 | |||||
Thrombocytosis
|
12 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 0.920 | 25 | 2006 | 2018 | |||||
MYELODYSPLASTIC SYNDROME
|
95 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 0.929 | 14 | 2005 | 2018 | |||||
Myelofibrosis
|
7 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 0.944 | 72 | 2005 | 2019 | |||||
Polycythemia Vera
|
38 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.900 | 0.960 | 274 | 2005 | 2019 | |||||
Leukemia, Myelocytic, Acute
|
6892 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.900 | 0.966 | 29 | 2005 | 2019 | |||||
Primary Myelofibrosis
|
29 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.800 | 0.966 | 175 | 2005 | 2020 |